– Leading Pharmaceutical CDMO, Formerly Ascendia Pharmaceuticals, Re-brands to Better Reflect Expanding Capabilities – NORTH BRUNSWICK, N.J., Dec. 9, 2024 /PRNewswire/ — Jim Huang, Ph.D., founder and CEO of Ascendia Pharmaceuticals, announces that the pharmaceutical contract development…